1. Duke University School of Medicine, Durham, North Carolina; and
2. National Institutes of Health/Pfizer Clinical Research Training Program,
3. Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases, and
4. Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, and
5. Dermatology Branch and
6. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland